Comparing blood thinners for ECMO support
Treatments studied
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial compares three different blood thinners (heparin, argatroban, and enoxaparin) used during ECMO support. It aims to find the safest and most effective way to prevent blood clots while on ECMO.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are on ECMO (a heart-lung machine) or need to start it within 12 hours
- You do not have any condition that prevents you from taking blood thinners (like heparin, argatroban, or enoxaparin)
- You are not pregnant
- You were not already on a blood thinner before ECMO was started
- ECMO was not started during CPR (chest compressions)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using lower doses of two blood thinners, argatroban and enoxaparin, is safe and works well for people on ECMO. ECMO is a machine that helps your heart and lungs work when they are very sick, and this trial aims to reduce bleeding risks while keeping blood from clotting.
This study looks at whether a blood test measuring a substance called anti-factor Xa activity can help predict dangerous blood clots in critically ill patients. If you join, researchers will follow you to see if the test results can prevent clots.
This Phase 2 trial compares two blood-thinning medicines—bivalirudin and heparin—in people on ECMO (a machine that supports breathing and/or circulation). It aims to see which medicine works better and is safer while you are connected to the ECMO circuit.
This trial studies whether people on a breathing machine called VV-ECMO can be managed without routine blood thinners, to reduce bleeding risk. It is meant for adults with severe lung failure (ARDS) and checks that it is safe for you to avoid anticoagulation.
This trial tests if bivalirudin is a safe and effective blood thinner for people on ECMO, a machine that helps your heart and lungs. You may be eligible if you need this therapy and have no past reactions to similar medicines.
This trial tests a way to manage blood clotting in patients on ECMO (a machine that helps breathe for very sick patients). It uses a drug called Nafamostat with a lower dose of standard blood thinners, which may reduce bleeding risks.
Hear when a new Respiratory Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.